Aurinia Pharmaceuticals Inc. v. DifGen Pharmaceuticals LLC
| Delaware District Court | |
| Judge: | Jennifer L Hall |
| Case #: | 1:25-cv-00530 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:271 Patent Infringement |
| Case Filed: | May 01, 2025 |
| Last checked: Thursday May 01, 2025 2:05 PM EDT |
|
Defendant
DifGen Pharmaceuticals LLC
|
|
|
Plaintiff
Aurinia Pharmaceuticals Inc.
|
Represented By
|
| Docket last updated: 05/09/2025 11:59 PM EDT |
| Wednesday, May 07, 2025 | ||
|
utility
Case Assigned/Reassigned
Wed 05/07 9:33 AM
Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (alb) |
||
| Thursday, May 01, 2025 | ||
| 6 | 6
service
Summons Issued
Thu 05/01 1:46 PM
Summons Issued as to DifGen Pharmaceuticals LLC on 5/1/2025. (scs) |
|
| 5 | 5
misc
Disclosure Statement - Rule 7.1
Thu 05/01 1:44 PM
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurinia Pharmaceuticals Inc. (scs) |
|
| 4 | 4
misc
Patent/Trademark Report to Commissioner of Patents
Thu 05/01 1:43 PM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,286,036; 11,622,991. (scs) |
|
| 3 | 3
misc
ANDA Form
Thu 05/01 1:42 PM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 18, 2025. Date of Expiration of Patent: December 7, 2037. Thirty Month Stay Deadline: 9/18/2027. (scs) |
|
| 2 | 2
misc
Magistrate Consent Forms
Thu 05/01 1:40 PM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
|
| 1 | 1
11
pgs
cmp
Complaint
Thu 05/01 1:39 PM
COMPLAINT for Patent Infringement against DifGen Pharmaceuticals LLC (Filing fee $ 405, receipt number ADEDC-4676008) - filed by Aurinia Pharmaceuticals Inc..(scs) |
|
|
Att: 1
Exhibits 1-2,
|
||
|
Att: 2
Civil Cover Sheet
|
||